2020
DOI: 10.1016/j.clindermatol.2020.03.012
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 pandemic and the skin: what should dermatologists know?

Abstract: Journal Pre-proof J o u r n a l P r e -p r o o f 2 Running title: COVID-19 and the skin Conflict of interests: none Funding sources: none Acknowledgements: none Journal Pre-proof J o u r n a l P r e -p r o o f 3 AbstractThe World has changed dramatically since the COVID-19 pandemic began. Together with our social, occupational, and personal life, the new corona virus poses novel challenges for all physicians, including dermatologists. Despite the virus not being dermatotropic, several skin conditions have emer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
197
1
12

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 196 publications
(211 citation statements)
references
References 4 publications
1
197
1
12
Order By: Relevance
“…The COVID-19 infection, as an airborne high consequence of infectious disease, has an incubation period of 0 to 14 days [5]. The symptoms range from mild to severe complications including fever, cough, shortness of breath, pneumonia and respiratory, hepatic, gastrointestinal, renal, cutaneous and neurological complications and nally death occurs in severe cases [5][6][7][8]. The key principles for COVID-19 prevention are to identify potential cases as soon as possible, prevent transmission of the infection to other people and avoid direct contact with respiratory secretions and isolating the patients [9].…”
Section: Introductionmentioning
confidence: 99%
“…The COVID-19 infection, as an airborne high consequence of infectious disease, has an incubation period of 0 to 14 days [5]. The symptoms range from mild to severe complications including fever, cough, shortness of breath, pneumonia and respiratory, hepatic, gastrointestinal, renal, cutaneous and neurological complications and nally death occurs in severe cases [5][6][7][8]. The key principles for COVID-19 prevention are to identify potential cases as soon as possible, prevent transmission of the infection to other people and avoid direct contact with respiratory secretions and isolating the patients [9].…”
Section: Introductionmentioning
confidence: 99%
“…Whilst specific cutaneous sequelae due to COVID-19 itself have not yet been described, skin problems related to PPE worn during the pandemic are emerging, and have recently been recognized in the document published in April 2020 by NHS England which provides advice on how to prevent facial skin damage beneath PPE. [1][2] This document advocates use of a skin protectant if wearing PPE for extended periods, and promotes regular breaks (ideally every 2 h) from wearing a FFP mask to relieve tissue pressure and reduce humidity. The chosen barrier cream or tape should not compromise the integrity or fit of the mask.…”
Section: Referencesmentioning
confidence: 99%
“…We postulate that the cutaneous complications reported during the COVID-19 pandemic stem from the hyperhidrotic effect of PPE, friction, epidermal breakdown, pressure urticaria and contact dermatoses, all of which may be exacerbated in the context of pre-existing skin disease. 1,3 Experience from previous pandemics has shown skin inflammation and erythema, papules, maceration and scaling to be the most frequently reported adverse cutaneous outcomes of extended PPE use, with the most commonly affected sites being the nasal bridge, cheeks, forehead and hands. 4 Here, we report individual cases of two female theatre nurses working within the same surgical unit within the United Kingdom during the current COVID-19 pandemic, neither with preexisting skin disease.…”
Section: Referencesmentioning
confidence: 99%
“…6 The skin problems in the COVID-19 infection were originally due to the over hydration effect of PPE, maceration, rubbing, epidermal barrier impairment, and contact response, all of which may exacerbate a present cutaneous disease. 6,7 The most frequently reported adverse cutaneous outcomes of extended PPE use were skin in ammation, redness, papules, and scaling, with the most commonly affected sites being the face especially the nose, cheeks, forehead, and hands. 8 A localized facial miliaria and headache were reported secondary to a facial mask.…”
Section: Introductionmentioning
confidence: 99%